In a murine model of experimental autoimmune encephalitis, IDO deficient mice show exacerbation of encephalitis, which can be inhibited by treatment with tryptophan metabolite 3-hydroxyanthranilate (3-HAA), generated during IDO mediated tryptophan catabolism. The gene discussed is IDO1; the disease is encephalitis.